Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H9NO |
| Molecular Weight | 123.1525 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCC1=NC=CC=C1
InChI
InChIKey=BXGYBSJAZFGIPX-UHFFFAOYSA-N
InChI=1S/C7H9NO/c9-6-4-7-3-1-2-5-8-7/h1-3,5,9H,4,6H2
| Molecular Formula | C7H9NO |
| Molecular Weight | 123.1525 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Bis[2-(pyridin-2-yl)ethanol-κN,O]bis-(thio-cyanato-κN)nickel(II). | 2010-11-17 |
|
| Nuclearity of nickel and mixed sodium-nickel complexes: dependence on the spacer in chelating pyridine-alcoholate ligands. | 2010-09-21 |
|
| Family of Mn(III)(2)Ln(2)(mu(4)-O) compounds: syntheses, structures, and magnetic properties. | 2010-06-07 |
|
| Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis. | 2010-03 |
|
| Bis(dicyanamido-κN)bis-[2-(2-hydroxy-ethyl)pyridine-κN,O]nickel(II). | 2009-11-07 |
|
| Vapor-diffusion-mediated single crystal-to-single crystal transformation of a discrete dimeric copper(II) complex to a discrete tetrameric copper(II) complex. | 2009-06-01 |
|
| 2,2'-Diamino-N,N'-(o-phenyl-ene)di-benz-amide. | 2009-03-25 |
|
| Oxethazaine as the source of mephentermine and phentermine in athlete's urine. | 2009-03-10 |
|
| Bis[2-(2-hydroxyethyl)pyridinium] mu-decavanadato-bis[pentaaquamanganate(II)] tetrahydrate. | 2009-02 |
|
| Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. | 2007-05-09 |
|
| Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. | 2007-04 |
|
| Palladium-catalyzed 2-pyridylmethyl transfer from 2-(2-pyridyl)ethanol derivatives to organic halides by chelation-assisted cleavage of unstrained C(sp3 )--C(sp3) bonds. | 2007 |
|
| Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety. | 2006-08-15 |
|
| Intrahepatic flow disturbance: possibility of a hidden cause of drug toxicity. | 2006-03 |
|
| Mechanisms involved in the contraction of intrahepatic portal vein branches by clomipramine and oxethazaine in isolated perfused rat livers. | 2005-06 |
|
| Single-molecule magnets: structure and properties of [Mn18O14(O2CMe)18(hep)4(hepH)2(H2O)2](ClO4)2 with spin S = 13. | 2005-02-07 |
|
| [Clinical study on the pharmacological treatment of hemorrhoids with 0.25% oxethacaine chlorhydrate]. | 2004-10 |
|
| Large spin differences in structurally related Fe6 molecular clusters and their magnetostructural explanation. | 2004-09-06 |
|
| Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol. | 2003-09-15 |
|
| Quantum tunneling of magnetization in a new [Mn18]2+ single-molecule magnet with s = 13. | 2002-08-21 |
|
| Biphasic effects of oxethazaine, a topical anesthetic, on the intracellular Ca(2+) concentration of PC12 cells. | 2002-08-15 |
|
| Metabolism of a thiazole benzenesulfonamide derivative, a potent and elective agonist of the human beta3-adrenergic receptor, in rats: identification of a novel isethionic acid conjugate. | 2002-07 |
|
| Single-molecule magnets: a new family of Mn(12) clusters of formula [Mn(12)O(8)X(4)(O(2)CPh)(8)L(6)]. | 2002-04-10 |
|
| Effects of betahistine and of its metabolites on vestibular sensory organs. | 2001-06 |
|
| Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. | 2001-04 |
|
| [Separation of oxetacaine and its metabolites] . | 2001-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:55:58 GMT 2025
by
admin
on
Mon Mar 31 21:55:58 GMT 2025
|
| Record UNII |
4G94J9B8JR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID2044767
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY | |||
|
77979
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY | |||
|
103-74-2
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY | |||
|
203-140-2
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY | |||
|
2144
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY | |||
|
4G94J9B8JR
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY | |||
|
7675
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY | |||
|
5357
Created by
admin on Mon Mar 31 21:55:58 GMT 2025 , Edited by admin on Mon Mar 31 21:55:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
